Extended hormone therapy may help some women with ER+ breast cancer
Genetic analyses of results from 1125 postmenopausal women being treated for oestrogen responsive breast cancer have shown that some of them are more likely than others to have a late recurrence of their cancer and might benefit from ten years of hormone therapy rather than five.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Breast Cancer Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Genetics | Health | Hormonal Therapy | Hormones | Women